In view of the rapidly growing number of reports and the impact of the COVID-19 coronavirus on public health, ESHRE has formed a specialist working group to keep track of bibliography and published scientific reports relevant to reproductive medicine, pregnancy and newborns.
This working group comprises
Anna Veiga (ES), Coordinator
Kersti Lundin (SE)
Juha Tapanainen (FI)
Luca Gianaroli (IT)
Edgar Mocanu (IRL)
Baris Ata (TR)
Satu Rautakallio-Hokkanen (Fertility Europe) (joined on 9 April 2020)
and will be supported by Nathalie Vermeulen, ESHRE Senior Research Specialist.
The working group's aims are to:
29 May 2020
The COVID-19 pandemic presents a unique global challenge on a scale not previously seen. The infectivity and mortality rates are higher than previous pandemics and the disease is present in almost every country. In this document, ASRM, ESHRE and the International Federation of Fertility Societies (IFFS) have come together to jointly affirm the importance for continued reproductive care during the COVID-19 pandemic.
Read here >
23 April 2020
As the COVID-19 pandemic is stabilising, the return to normal daily life will also see the need to restart the provison of ART treatments. Infertility is a disease and once the risk of SARS-CoV-2/COVID-19 infection is decreasing, all ART treatments can be restarted for any clinical indication, in line with local regulations.
However, vigilance and measured steps must be taken for safe practice and to minimise the risks related to SARS-CoV-2/COVID-19-positive patients or staff during treatment.
The ESHRE COVID-19 working group has prepared the “ESHRE Guidance on recommencing ART treatments”, a set of recommendations for centres planning to restart ART treatments.
Read the full Guidance here
MAR/ART & COVID-19 - A Picture of Europe
Picture of the impact of COVID-19 on the MAR/ART centres and treatments in Europe
Questions & Answers
- Q and A for MAR patients
- Q and A for professionals
Has a COVID-19 infection been confirmed in one of your pregnant IVF patients?
Please report the case to our platform. The anonymous information will be a piece in the puzzle and help us to answer critical questions with regards to the impact of COVID-19 on our patients.
Have you contributed? We highlighted your country on our map.
Please note that if you reported an ongoing pregnancy and/or want to provide additional information, you provide updated information via e-mail to firstname.lastname@example.org
Going through the COVID-19 transition in the IVF lab: how can quality management help?
-> Watch the recording
-> Download Q&A's
COVID-19 and ART
-> Watch the recording
Links to COVID-19 resources
Archive of statements on assisted reproduction and COVID-19
Share this page